The global sales of aquaculture vaccines is estimated to be worth USD 473.8 million in 2025 and anticipated to reach a value of USD 1,079.6 million by 2035. Sales are projected to rise at a CAGR of 8.6% over the forecast period between 2025 and 2035. The revenue generated by aquaculture vaccines in 2024 was USD 440.9 million.
The aquaculture vaccines market is part of the wider aquaculture industry that aspires to promote health and productivity in farmed aquatic species such as fish. The vaccines are manufactured with the objective of preventing and controlling disease in fish and other aquatic animals, reducing dependency on antibiotics, and lessening the risks associated with AMR.
The market offers three different types of vaccines-inactivated, live attenuated, and recombinant vaccines-designed specifically for the species of salmon, tilapia, carp, and catfish. Aquaculture vaccines hold an important place in ensuring the sustainability of aquaculture; infections from bacteria, viruses, and parasites solved by aquaculture vaccines mean fish farming would always be a green and sustainable venture and always profitable.
Aquaculture Vaccines Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 440.9 million |
| Estimated Size, 2025 | USD 473.8 million |
| Projected Size, 2035 | USD 1,079.6 million |
| CAGR (2025 to 2035) | 8.6% |
Aquaculture vaccines also are growing markets in the modern era, based on the fact that more seafood has to be provided and the fishes farmed within water bodies kept healthy. It is a requirement around the world with the increase in seafood consumption for aquatic animals to be kept healthy. The factor of disease prevention, along with advancements in technology for vaccines, has made the vaccines indispensable in sustainable fish farming.
Disease outbreaks have always been the biggest challenge, with many fish dying and leading to losses. Vaccination has become indispensable since it controls the diseases, improves survival, enhances productivity, and raises farm profitability. Common pathogens in fish farms include Aeromonas, Vibrio, and the virus that causes infectious salmon anemia; thus, vaccinations are a necessary management strategy for these diseases.
The rising demand for seafood globally is another key driver of the aquaculture vaccines market. With seafood becoming increasingly popular for health benefits and as a protein source, aquaculture becomes necessary to meet the demand. Ensuring the health and productivity of farmed fish is critical for industry growth, making vaccines indispensable in sustainable aquaculture practices. Countries with significant aquaculture industries, such as Norway, Chile, Vietnam, and China, are investing heavily in vaccination programs through both public and private efforts. Government biosecurity measures and financial incentives further promote the use of vaccines, establishing a robust foundation for market expansion.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global aquaculture vaccines market compound annual growth rate (CAGR) for the first half of 2024 and 2025 is compared in the table below. This analysis provides important insights into the performance of the industry by highlighting significant shifts and trends in revenue generation.
The first half (H1) is the period from January to June, and the second half (H2) is July to December. In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 9.5%, followed by a slightly lower growth rate of 9.2% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 9.5% (2024 to 2034) |
| H2 | 9.2% (2024 to 2034) |
| H1 | 8.6% (2025 to 2035) |
| H2 | 8.2% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 8.6% in the first half and remain relatively lower at 8.2% in the second half. In the first half (H1) the industry witnessed a decrease of 90 BPS while in the second half (H2), the industry witnessed a decrease of 100 BPS.
Increasing Demand for Disease Control in Aquaculture is driving the Aquaculture Vaccines Market Growth
Over the past few years, infectious diseases have been affecting fish farming to a greater extent, which underlines the urgent need for effective and sustainable prevention strategies. Disease outbreaks reduce fish harvests but heavily affect the financial success of fish farms. Vaccines have become a key solution by making farmed fish immune to these diseases, thus lowering infection rates and severity.
Unlike antibiotics, which are limited to treating bacterial infections and may lead to resistance, vaccines prevent diseases from occurring in the first place, offering a proactive approach to managing fish health.
Governments and fish farming organizations globally are advocating for vaccines as part of comprehensive plans to improve farm biosecurity and minimize risks. Furthermore, vaccines are economically advantageous for large-scale operations as they decrease fish mortality and enhance feed conversion efficiency.
Shift Toward Antibiotic-Free Farming Practices is driving Revenue Growth for Aquaculture Vaccines
The main concern with excessive antibiotic use in aquaculture is the risk of developing resistance pathogens, leading to risks of pathogen infections on animals and potentially in humans as well. The sustainability of this method is feasible as vaccines could prevent infections rather than using antibiotics.
It corresponds to consumer demands for sustainably farmed seafood products and also to retailer demand for antibiotic-free certifications. This is further pushed by governments and international organizations in the form of encouraging vaccination as a primary mode of disease management.
For instance, there are some incentives to farmers in some countries by introducing vaccination programs and adherence to biosecurity standards. The market demand together with this regulatory push is pushing forward the vaccines throughout the industry.
Besides, the practice of antibiotics free makes the products of aquaculture more globally competitive and allows new export markets for the producers. Due to this shift toward sustainability, the trend is likely to continue to act as a driver for the aquaculture vaccines market.
Advancements in Vaccine Delivery Systems is Creating Opportunities in the Market
Advancements in oral and immersion vaccine technologies are transforming the landscape by making vaccine administration more efficient and accessible. Oral vaccines can be included in fish feed, which is a very convenient method for farmers since it does not require manual handling of fish. Immersion vaccines are also immersed in a vaccine solution and allow for the immunization of large groups at once.
They not only save time and reduce labor costs but also minimize stress on the fish, further improving health outcomes. These innovations are a great boon for small and medium-scale farmers, who would otherwise do not have the wherewithal to invest into traditional vaccination approaches.
The market participants can expand accessibility of vaccines while tapping into less-visited areas and thus reap new growth potential, by investing in these technologies and solving various logistical and financial problems in the industry.
High Costs for Small-Scale Farmers and Regulatory Challenges may Restrict Market Growth
While vaccines play a big role in disease prevention, it is a great challenge for the small-scale fish farmers. Getting the vaccines can be expensive since one has to purchase them and store them in the right temperatures of cold. There is also a cost of having the skilled manpower to administer these vaccines.
They are very significant players in the fish farming business but operate with very thin profit margins. Vaccines require a specific temperature to remain active; therefore, the lack of cold storage in far-flung or poor economies creates a significant problem for farmers.
Lacking proper training and technical assistance, farmers may not administer vaccines correctly, which decreases their effectiveness and discourages future use. To address these challenges, solutions like government subsidies, partnerships with vaccine manufacturers, and more affordable delivery systems are needed. Without this kind of support, small farmers are unlikely to adopt vaccines, which restricts the growth potential of the market.
The global aquaculture vaccines industry recorded a CAGR of 7.1% during the historical period between 2020 and 2024. The growth of aquaculture vaccines industry was positive as it reached a value of USD 440.9 million in 2024 from USD 335.7 million in 2020.
The aquaculture vaccines market has undergone significant changes due to advancements in technology, increased focus on sustainable farming, and concerns about disease outbreaks. Initially, growth in this market was slow because effective vaccines were limited, and the industry relied mainly on antibiotics. Vaccination efforts were mainly concentrated on high-value fish like salmon, with little use in other areas. High costs of developing vaccines and distribution challenges were significant hurdles, especially for smaller farmers.
Governments worldwide are enforcing stricter safety measures, promoting vaccines as a key method for disease prevention. The emergence of new technologies, including better vaccines, improves effectiveness and availability, hence their popularity among farmers.
The growing antibiotic resistance concern is also shifting attention from the use of antibiotics toward vaccines as the alternative choice for sustainability. High capital investment in research by big companies has made the vaccines range expand to more varieties for species and disease types.
Looking ahead, the aquaculture vaccines market is expected to grow significantly, with advancements in vaccine technology and delivery playing crucial roles. Oral and immersion vaccines are anticipated to ease distribution challenges, especially for smaller farmers, by simplifying administration and cutting costs.
The future of the market also offers hope for resolving environmental and sustainability issues. By reducing the necessity for antibiotics, vaccines decrease the environmental impact of aquaculture operations. This is in line with the international movement toward sustainable seafood production, which is now gaining consumer and retailer support. However, in order to tap into the full potential of the market, challenges such as high costs for small farmers and distribution issues need to be overcome.
Tier 1 companies are the industry leaders with 43.5% of the global industry. These companies stand out for having a large product portfolio and a high production capacity. These industry leaders also stand out for having a wide geographic reach, a strong customer base, and substantial experience in manufacturing and having enough financial resources, which enables them to enhance their research and development efforts and expand into new industries.
The companies within tier 1 have a good reputation and high brand value. Prominent companies within tier 1 include Zoetis Inc., Merck Animal Health, Elanco Animal Health and HIPRA
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a market share of 36.5% worldwide. These firms may not have cutting-edge technology or a broad global reach, but they do ensure regulatory compliance and have good technology. The players are more competitive when it comes to pricing and target niche markets. Key Companies under this category include Benchmark Holdings, Pharmaq, Veterquimica among others
Compared to Tiers 1 and 2, Tier 3 companies offer outsourced testing services, but with smaller revenue and less influence. These companies mostly operate in one or two countries and have limited customer base. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The market analysis for aquaculture vaccines in various nations is covered in the section below. An analysis of important nations in North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East & Africa of the world has been mentioned below. It is projected that the United States will maintain its leading position in North America through 2035, holding a value share of 89.8%. By 2035, China is expected to experience a CAGR of 8.1% in the Asia-Pacific region.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 4.7% |
| Germany | 5.2% |
| UK | 4.5% |
| Norway | 6.7% |
| Chile | 7.1% |
| Vietnam | 7.8% |
| China | 8.1% |
Germany's aquaculture vaccine market is strong due to its strict regulations and commitment to sustainable farming. As a leader in the EU, Germany enforces measures to cut antibiotic use and support sustainable aquaculture. The country follows EU rules by banning certain antibiotics and monitoring antibiotic resistance, which has led to more vaccine use for preventing fish diseases.
Germany's advanced research facilities have significantly improved vaccine technology, creating vaccines that protect against more diseases.
The rising demand for high-quality, antibiotic-free seafood in Germany further increases vaccine adoption. Efficient systems for keeping vaccines cold and strong veterinary support ensure smooth distribution and use. Government, research institutions, and private companies work together to innovate and expand vaccination programs, particularly for valuable fish like trout and carp.
These efforts, along with Germany's focus on environmental sustainability and animal welfare, drive the growth of the aquaculture vaccine market.
Chile, one of the world's largest producers of farmed salmon, has seen rapid growth in its aquaculture vaccines market due to the pressing need for disease control in its salmon farming industry. Outbreaks of infectious diseases such as infectious salmon anemia (ISA) and salmonid rickettsial septicemia (SRS) have caused significant economic losses, prompting the industry to prioritize vaccination programs.
The government of Chile has taken a proactive role in promoting biosecurity measures, offering subsidies and technical support to encourage vaccine adoption.
Additionally, the country's strong export orientation, particularly to markets in North America and Europe, drives compliance with international sustainability standards, which emphasize reduced antibiotic usage. Chile's collaboration with global pharmaceutical companies has led to the development of tailored vaccines for local aquaculture conditions, further improving disease management.
The emergence of innovative vaccine delivery systems, such as immersion and oral vaccines, is addressing logistical challenges, making vaccination more accessible to small and medium-scale farmers. The combination of governmental support, international market demands, and ongoing innovation positions Chile as a key player in the global aquaculture vaccines market.
China is the world's largest producer of farmed fish and seafood and has a rapidly developing vaccines market, driven by that country's high production of fish and seafood and adoption of environmentally sustainable farming practices. Diseases, largely bacterial and viral, pose a strong threat to production, affecting mainly carp, tilapia, and shrimp.
To address these issues, the Chinese government has enacted policies aimed at reducing antibiotic use in fish farming, aligning with international efforts to combat antibiotic resistance and guarantee the safety of seafood exports. The provision of financial incentives and subsidies for vaccine research and implementation has also propelled market growth.
High-quality and affordable, the vaccines would henceforth be manufactured within China; China's far-stretching aquaculture and biotechnologies further helped manufacture and make cheaper to the people such vaccines as farmers needed vaccines, and, increasing consumer appetite for safe seafood antibiotic free, including Artificial intelligence in fish farms, particularly regarding disease-monitoring and controlling software for better effectuation of immunoprophylactics.
The section contains information about the leading segments in the industry. Based on vaccine type, the inactivated vaccines segment is expected to account for 53.5% of the global share in 2025.
| By Vaccine type | Value Share (2025) |
|---|---|
| Inactivated Vaccines | 53.5% |
Inactivated vaccines currently dominate the market in aquaculture vaccines because of their high safety, diversity, and capability to prevent disease in fish. These are prepared by destroying the pathogenic nature of pathogens but retaining its ability to initiate an immune response so that these cannot become dangerous again. This safety aspect makes them preferred in aquaculture, where preventing disease outbreaks is essential for maintaining high production and economic stability.
These vaccines are particularly effective against bacterial infections like vibriosis, yersiniosis, and enteric redmouth disease, which are widespread in fish farming worldwide. They provide long-lasting protection, often requiring just one dose, which is attractive to fish farmers.
Inactivated vaccines can be administered in various ways, including injections, immersion, or orally, making them suitable for different aquaculture setups. Their use supports global efforts to cut down on antibiotic use, offering a sustainable method for managing diseases.
| By Fish Species | Value Share (2025) |
|---|---|
| Salmon | 84.6% |
The main reason Salmon dominates the market of aquaculture vaccines is due to its value and susceptibility to disease. Since salmon is highly prized seafood, North America, Europe, and Asia-Pacific highly consume it, making massive large-scale salmon farming prevalent. It would cause major losses if these were to face an outbreak.
Such common issues that have often posed challenges in its production are ISA, SRS, and sea lice infestations. Hence, it needs vaccination against these diseases. The development of specific vaccines for salmon has made their use common in the industry.
In terms of this market, the companies involved are resorting to multiple strategies to retain a competitive position. Geographical expansion into the emerging markets, particularly United States and Asia Pacific countries, has been another strategic priority for these companies, where growth in the healthcare infrastructure and awareness is strong.
Recent Industry Developments in Aquaculture Vaccines Industry Outlook
In terms of vaccine type, the industry is divided into Inactivated Vaccines, DNA and Recombinant Vaccines, Live Attenuated Vaccines, Subunit Vaccines among Others
In terms of fish species, the industry is segregated into Salmon, Tilapia, Catfish, Carp, Shrimp and Other Species.
In terms of pathogen, the industry is segregated into bacteria, virus and others.
In terms of end user, the industry is divided into commercial aquaculture farms, small-scale farmers in emerging markets, government and cooperative programs, research institutions and diagnostic labs.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East and Africa (MEA) have been covered in the report.
The global aquaculture vaccines industry is projected to witness CAGR of 8.6% between 2025 and 2035.
The global aquaculture vaccines industry stood at USD 440.9 million in 2024.
The global aquaculture vaccines industry is anticipated to reach USD 1,079.6 million by 2035 end.
China is expected to show a CAGR of 8.1% in the assessment period.
The key players operating in the global aquaculture vaccines industry are Zoetis Inc. , Merck Animal Health, Elanco Animal Health, HIPRA, Benchmark Holdings, Pharmaq, Veterquimica, Pear Therapeutics, Centrovet, Weihai Weihao Bioengineering, PHARMAQ, AquaGen among others.
Explore Animal Health Therapeutics Insights
View Reports
Aquaculture Vaccines Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
